找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of Breast Diseases; Ismail Jatoi,Achim Rody Book 2016Latest edition Springer International Publishing Switzerland 2016 Breast I

[復(fù)制鏈接]
樓主: 自治
31#
發(fā)表于 2025-3-27 00:08:40 | 只看該作者
32#
發(fā)表于 2025-3-27 02:49:14 | 只看該作者
33#
發(fā)表于 2025-3-27 08:28:39 | 只看該作者
Surgical Considerations in the Management of Primary Invasive Breast Cancer,tomy (CPM), and breast-conserving surgery (BCS). Following BCS, radiation therapy (RT) is often required to reduce the risk of ipsilateral breast tumor recurrence, although older patients with indolent tumors may not require radiotherapy after BCS. Moreover, radiotherapy is required for selected hig
34#
發(fā)表于 2025-3-27 09:26:46 | 只看該作者
Management of the Axilla,nd accepted as standard of care worldwide. Dual localization methods with blue dye and radioisotope are associated with optimal performance parameters such as shorter learning curve, higher identification rates and low false-negative rates. Several issues relating to surgical technique and choice of
35#
發(fā)表于 2025-3-27 16:31:24 | 只看該作者
Breast Reconstructive Surgery,mmetrical breast mound after mastectomy. Breast reconstruction can be at the time of mastectomy or as a delayed procedure. Options for reconstruction include prosthetic implants, autologous tissue, or both. Implant reconstruction is a relatively simple and effective method of breast reconstruction,
36#
發(fā)表于 2025-3-27 20:43:08 | 只看該作者
The Role of Radiotherapy in Breast Cancer Management, recurrent carcinoma of the breast. Despite the technical limitations of the early equipment, tumor shrinkage and at times complete elimination of the tumor were noticed. However, the full potential of radiation therapy could not be achieved in those early days because of the limited knowledge regar
37#
發(fā)表于 2025-3-28 01:04:14 | 只看該作者
38#
發(fā)表于 2025-3-28 04:39:19 | 只看該作者
Endocrine Therapy,ausal women, tamoxifen is the standard in low-risk patients, providing a significant reduction in both risk of recurrence and BC mortality; the addition of ovarian function suppression (OFS) to tamoxifen or the aromatase inhibitor (AI) Exemestane is recommended in patients at higher risk of relapse.
39#
發(fā)表于 2025-3-28 07:04:14 | 只看該作者
40#
發(fā)表于 2025-3-28 13:46:58 | 只看該作者
http://image.papertrans.cn/m/image/622451.jpg
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
玉龙| 万源市| 光山县| 洞头县| 师宗县| 菏泽市| 年辖:市辖区| 北川| 秀山| 汝城县| 海口市| 慈利县| 万载县| 兴安盟| 额尔古纳市| 瑞昌市| 桦南县| 响水县| 应用必备| 巴彦淖尔市| 临沂市| 阿鲁科尔沁旗| 塔河县| 曲松县| 明溪县| 阳泉市| 长垣县| 灵武市| 讷河市| 永福县| 平山县| 娄底市| 彭水| 达拉特旗| 阿拉尔市| 会昌县| 麻江县| 辽中县| 文登市| 德兴市| 博白县|